van den Brink,Wim

Institution: Netherlands Institute of Mental Health and Addiction, Netherlands

Top Collaborators: Koeter MW, Brunt TM, Schippers GM, Niesink RJ, Merkx MJ, Vuijk PJ, Van Amsterdam J, Booij J, Blanken P, Hendriks VM, Van Ree JM, Crunelle CL, Van Emmerik-van Oortmerssen K, Bladström A, Torup L, Gual A, Poch M, Van Laar M, Kronemeijer H, Kahn RS

Research Interests: Treatment, Patients, Risk, Health, Drugs, Consumption, Literature, Relapse, Paper, Treatments, Heroin, Alcohol Consumption, Role, Evaluation, Drinking, Attention, Prevalence, Report, Illicit Drugs, Cue

Publications

Information and abstracts for author publications
Published Date	Impact	Publication
12/11/2012	8.3	Biological psychiatry Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefene.	Abstract
12/03/2009	5.4	European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology The nicotinic acetylcholine receptor partial agonist varenicline and the treatment of drug dependence: a review.	Abstract
06/15/2009	4.8	Addiction biology Predicting the effect of naltrexone and acamprosate in alcohol-dependent patients using genetic indicators.	Abstract
10/20/2011	4.7	Schizophrenia research Predictive validity of a culturally informed diagnosis of schizophrenia: a 30 month follow-up study with first episode psychosis.	Abstract
02/06/2012	4.7	Schizophrenia research Effect of cannabis use on the course of schizophrenia in male patients: a prospective cohort study.	Abstract
11/17/2009	4.3	Addiction (Abingdon, England) Outcome of long-term heroin-assisted treatment offered to chronic, treatment-resistant heroin addicts in the Netherlands.	Abstract
03/10/2010	4.3	Addiction (Abingdon, England) Measurements in the Addictions for Triage and Evaluation (MATE): an instrument based on the World Health Organization family of international classifications.	Abstract
08/29/2008	4.2	Acta psychiatrica Scandinavica Validity of 'post-traumatic stress disorder with secondary psychotic features': a review of the evidence.	Abstract
10/13/2011	4.1	Psychopharmacology Linking the pharmacological content of ecstasy tablets to the subjective experiences of drug users.	Abstract
06/26/2014	3.9	Current pharmaceutical design GHB, GBL and 1,4-BD addiction.	Abstract
09/08/2010	3.4	Journal of psychopharmacology (Oxford, England) Instability of the ecstasy market and a new kid on the block: mephedrone.	Abstract
07/02/2013	3.4	Journal of psychopharmacology (Oxford, England) Reduced-risk drinking as a viable treatment goal in problematic alcohol use and alcohol dependence.	Abstract
01/16/2013	3.4	Journal of psychopharmacology (Oxford, England) The high harm score of alcohol. Time for drug policy to be revisited?	Abstract
02/16/2012	3.4	Drug and alcohol dependence Screening for bipolar disorders in patients with alcohol or substance use disorders: performance of the mood disorder questionnaire.	Abstract
01/16/2013	3.4	Drug and alcohol dependence Sociodemographic and substance use characteristics of γ hydroxybutyrate (GHB) dependent inpatients and associations with dependence severity.	Abstract
09/29/2012	3.4	Drug and alcohol dependence Impulsivity in adult ADHD patients with and without cocaine dependence.	Abstract
07/22/2011	3.4	Drug and alcohol dependence Craving and illicit heroin use among patients in heroin-assisted treatment.	Abstract
05/02/2010	3.4	Drug and alcohol dependence The relationship of quality and price of the psychostimulants cocaine and amphetamine with health care outcomes.	Abstract
05/24/2011	2.5	European addiction research Efficacy of N-acetylcysteine in the treatment of nicotine dependence: a double-blind placebo-controlled pilot study.	Abstract
08/27/2009	2.5	International journal of methods in psychiatric research Blinding in clozapine trials: a problem and a potential solution.	Abstract
09/11/2013	2.5	International journal of methods in psychiatric research The International ADHD in Substance Use Disorders Prevalence (IASP) study: background, methods and study population.	Abstract
03/14/2012	2.4	Regulatory toxicology and pharmacology : RTP Risk assessment of gamma-hydroxybutyric acid (GHB) in the Netherlands.	Abstract
03/28/2013	2.4	Regulatory toxicology and pharmacology : RTP Physical harm due to chronic substance use.	Abstract
01/21/2011	2.4	Regulatory toxicology and pharmacology : RTP Harm potential of magic mushroom use: a review.	Abstract
12/21/2010	2.1	Addictive behaviors Guidelines for allocating outpatient alcohol abusers to levels of care: Predictive validity.	Abstract
09/12/2012	2.1	Addictive behaviors Predictive validity of treatment allocation guidelines on drinking outcome in alcohol-dependent patients.	Abstract